- Home
- BDSX
BDSX
Biodesix Inc.
as of 02-12-2026 3:37pm EST
$10.89
+$0.54
+5.17%
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | LOUISVILLE |
| Market Cap: | 88.3M | IPO Year: | 2020 |
| Target Price: | $32.50 | AVG Volume (30 days): | 332.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.44 - $20.40 | Next Earning Date: | 02-26-2026 |
| Revenue: | $80,173,000 | Revenue Growth: | 22.29% |
| Revenue Growth (this year): | 22.01% | Revenue Growth (next year): | 26.81% |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | -29157000.0 | FCF Growth: | N/A |
AI-Powered BDSX Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 69.87%
69.87%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Biodesix Inc. (BDSX)
Vazquez Chris
Sell
Chief Accounting Officer
BDSX Feb 10, 2026
Avg Cost/Share
$10.08
Shares
101
Total Value
$1,018.49
Owned After
1,234
SEC Form 4
Pestano Gary Anthony
Sell
Chief Development Officer
BDSX Feb 10, 2026
Avg Cost/Share
$10.08
Shares
540
Total Value
$5,445.41
Owned After
9,387
SEC Form 4
Cowie Robin Harper
Sell
CFO, Sec'y & Treasurer
BDSX Feb 10, 2026
Avg Cost/Share
$10.08
Shares
941
Total Value
$9,489.14
Owned After
15,297
SEC Form 4
O'Kane Kieran
Sell
Chief Commercial Officer
BDSX Feb 10, 2026
Avg Cost/Share
$10.08
Shares
584
Total Value
$5,889.11
Owned After
8,885
SEC Form 4
Hutton Scott
Sell
President & CEO
BDSX Feb 10, 2026
Avg Cost/Share
$10.08
Shares
3,559
Total Value
$35,889.31
Owned After
45,413
SEC Form 4
SCHULER JACK W
Buy
10% Owner, Other
BDSX Jan 26, 2026
Avg Cost/Share
$11.80
Shares
20,000
Total Value
$236,064.00
Owned After
1,563,210
SEC Form 4
SCHULER JACK W
Buy
10% Owner, Other
BDSX Jan 23, 2026
Avg Cost/Share
$11.81
Shares
80,000
Total Value
$944,672.00
Owned After
1,563,210
SEC Form 4
SCHULER JACK W
Buy
10% Owner, Other
BDSX Jan 22, 2026
Avg Cost/Share
$10.96
Shares
82,465
Total Value
$903,560.76
Owned After
1,563,210
SEC Form 4
Vazquez Chris
Sell
Chief Accounting Officer
BDSX Jan 16, 2026
Avg Cost/Share
$8.15
Shares
83
Total Value
$676.39
Owned After
1,234
SEC Form 4
Pestano Gary Anthony
Sell
Chief Development Officer
BDSX Jan 16, 2026
Avg Cost/Share
$8.15
Shares
298
Total Value
$2,428.49
Owned After
9,387
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Vazquez Chris | BDSX | Chief Accounting Officer | Feb 10, 2026 | Sell | $10.08 | 101 | $1,018.49 | 1,234 | |
| Pestano Gary Anthony | BDSX | Chief Development Officer | Feb 10, 2026 | Sell | $10.08 | 540 | $5,445.41 | 9,387 | |
| Cowie Robin Harper | BDSX | CFO, Sec'y & Treasurer | Feb 10, 2026 | Sell | $10.08 | 941 | $9,489.14 | 15,297 | |
| O'Kane Kieran | BDSX | Chief Commercial Officer | Feb 10, 2026 | Sell | $10.08 | 584 | $5,889.11 | 8,885 | |
| Hutton Scott | BDSX | President & CEO | Feb 10, 2026 | Sell | $10.08 | 3,559 | $35,889.31 | 45,413 | |
| SCHULER JACK W | BDSX | 10% Owner, Other | Jan 26, 2026 | Buy | $11.80 | 20,000 | $236,064.00 | 1,563,210 | |
| SCHULER JACK W | BDSX | 10% Owner, Other | Jan 23, 2026 | Buy | $11.81 | 80,000 | $944,672.00 | 1,563,210 | |
| SCHULER JACK W | BDSX | 10% Owner, Other | Jan 22, 2026 | Buy | $10.96 | 82,465 | $903,560.76 | 1,563,210 | |
| Vazquez Chris | BDSX | Chief Accounting Officer | Jan 16, 2026 | Sell | $8.15 | 83 | $676.39 | 1,234 | |
| Pestano Gary Anthony | BDSX | Chief Development Officer | Jan 16, 2026 | Sell | $8.15 | 298 | $2,428.49 | 9,387 |
Latest Biodesix Inc. News
BDSX Breaking Stock News: Dive into BDSX Ticker-Specific Updates for Smart Investing
Compare BDSX vs Leading Stocks
See how BDSX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "BDSX Biodesix Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.